Kevin Moreau

Kevin Moreau

Company: PROTAC Safety Science AstraZeneca

Job title: Associate Director


Panel Discussion: What Makes a Good Degrader? 3:30 pm

There is a current lack of protocols for making a successful degrader with good chemical matter. Being able to determine the parameters for what good look like and establishing common determinants will help the fast track development of the next generation of degraders. During the panel these key topics will be discussed: Understanding why early…Read more

day: Day Two

PROTAC Safety Perspective, Consideration For Oncology/Non-Oncology Indications 11:30 am

What are the potential PROTAC safety liabilities? Can we optimise the safety profile? What is an acceptable safety profile of non-oncology targets?Read more

day: Day 1 AM - Stream B

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.